4893 items matching your search terms.

Cardiovascular risk, renal status and fenofibrate safety in the FIELD study

Ting, R Davis, TME Drury, PL Donoghoe, M Rajamani, K Best, JD Kesaniemi, YA Keech, AC

Association of renal status and cardiovascular risk, and safety of fenofibrate in renal impairment in the FIELD study of 9795 subjects with type 2 diabetes

Ting, R Davis, TME Jenkins, AJ Drury, PL Donoghoe, MW Rajamani, JK Kesaniemi, AY Best, JD Keech, AC

Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes mellitus and renal impairment

Ting, R Donoghoe, M Jenkins, AJ Hedley, J Drury, PL Davis, TME Celermajer, D Simes, RJ Keech, AC

Triple negative and basal-like breast cancer in East Africa

Trinkaus, ME Sayed, S Gakinya, SM Moloo, Z Hanna, W Rahim, Y

Point-of-care prothrombin time testing in paediatric intensive care: an observational study of the ease of use of two devices

Urwyler, N Staub, E Staub, LP Daetwyler, K Fluri, S Sollberger, T Theiler, L Greif, R
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2011     DOI:10.1097/EJA.0b013e32834b7d65

Early change in tumor size from waterfall plot analysis and RECIST response as predictor of overall survival in advanced, chemotherapy-refractory colorectal cancer: NCIC CTG/AGITG CO.17 study

Van Hazel, GA Tu, D Tebbutt, NC Jonker, DJ Price, TJ O’Callaghan, C Zalcberg, JR Taylor, M Strickland, AH Tomiak, AT Yip, S Simes, J Yadav, SK Links, M Burnell, MJ Jefford, M Karapetis, CS

Determination of residual urine volume by translabial ultrasound

Velez, D Shek, K Martin, A Dietz, H

The influence of hypomagnesemia on overall survival in a phase III randomized study of cetuximab plus best supportive care versus BSC: NCIC CTG / AGITG CO.17

Vickers, M. M. Karapetis, C Tu, D. Zalcberg, J. O'Callaghan, C. Simes, J. Moore, M. Zhu, L. Jonker D.J.

Benefits of exercise training in patients receiving haemodialysis: a systematic review and meta-analysis

Wang, Y. Jardine, M. J.
BRITISH JOURNAL OF SPORTS MEDICINE, 2011     DOI:10.1136/bjsports-2011-090558

Vascular endothelial growth factors (VEGF) and VEGF receptor expression as predictive biomarkers for benefit with bevacizumab in metastatic colorectal cancer: analysis of the phase III MAX study

Weickhardt, A.J. Williams, D. Lee, C. Simes, J. Murone, C. Wilson, K. Cummins, M. M. Asadi, K. Price, T.J. Mariadason J. Tebbutt, N.C. Australasian Gastro-Intestinal Trials Group,

Should CA 125 still be part of tumour evaluation criteria in ovarian cancer trials? Experience of the GCIG CALYPSO trial

Alexandre, J Brown, C Priou, F De Rauglaudre, G Pfisterer, J Maenpaa, J Chalchal, H Marth, C Harris, B Vergote, IB

Phase II trial of combined temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy

Ananda, S Nowak, AK Cher, L Dowling, AJ Brown, C Simes, RJ Rosenthal, M

Inhaled nitric oxide in preterm infants: a systematic review and individual patient data meta-analysis

Askie, L Ballard, R Cutter, G Dani, C Elbourne, D Field, D Hascoet, JM Hibbs, A Kinsella, J Mercier, JC Rich, W Schreiber, M Srisuparp, P Subhedar, N Van Meurs, K Voysey, M Barrington, K Ehrenkranz, R Finer, N Meta-Analysis of Preterm Patients on Inhaled Nitric Oxide Collaboration,
BMC PEDIATRICS, 2010     DOI:doi:10.1186/1471-2431-10-15

Inhaled nitric oxide in preterm infants: an individual patient data meta-analysis

Askie, L Ballard, R Cutter, G Dani, C Elbourne, D Field, D Hascoet, J-M Hibbs, A-M Kinsella, J Mercier, J-C Schreiber, M Srisuparp, P Subhedar, N Van Meurs, K Voysey, M Barrington, K Ehrenkranz, R Finer, Neil

Inhaled nitric oxide in preterm infants: a individual patient data meta-analysis protocol; .

Askie, LM Carberry, AE on behalf of the MAPPiNO Collaboration,